Sina Neyazi

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Journal: Research square

Published: July 03, 2026

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Journal: Research square

Published: July 03, 2026

Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Journal: Nature

Published: May 06, 2026

Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomas.

Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomas.

Journal: bioRxiv : the preprint server for biology

Published: August 09, 2024

Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Journal: Nature

Published: August 07, 2024

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Journal: Cancer cell

Published: July 30, 2024

Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.

Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.

Journal: Acta neuropathologica

Published: April 22, 2024

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.

Journal: Acta neuropathologica

Published: October 05, 2023

Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.

Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.

Journal: Neuro-oncology

Published: September 28, 2023

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.

Journal: Cancer cell

Published: July 11, 2023

Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure.

Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure.

Journal: Cell reports. Medicine

Published: June 21, 2023

Molecular refinement of pilocytic astrocytoma in adult patients.

Molecular refinement of pilocytic astrocytoma in adult patients.

Journal: Neuropathology and applied neurobiology

Published: June 07, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026